2011
DOI: 10.1016/j.ajog.2010.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
44
0
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 48 publications
(47 citation statements)
references
References 33 publications
2
44
0
1
Order By: Relevance
“…A similar trend was found for HIV-1 RNA shedding in the genital tract of HIV-positive women. These findings are in agreement with the majority of studies that have also investigated these associations (Spear et al, 2008;Mitchell et al, 2009;Dols et al, 2011;Pépin et al, 2011;Schellenberg et al, 2011;Dols et al, 2012;Mitchell et al, 2013), but we are the first to report these associations for multiple STI pathogens and to demonstrate a dose-response relationship. It is important to note that the L. crispatus cluster only contained 11 women, and that the temporality of our findings is unclear because our study was cross-sectional.…”
Section: Discussionsupporting
confidence: 81%
See 3 more Smart Citations
“…A similar trend was found for HIV-1 RNA shedding in the genital tract of HIV-positive women. These findings are in agreement with the majority of studies that have also investigated these associations (Spear et al, 2008;Mitchell et al, 2009;Dols et al, 2011;Pépin et al, 2011;Schellenberg et al, 2011;Dols et al, 2012;Mitchell et al, 2013), but we are the first to report these associations for multiple STI pathogens and to demonstrate a dose-response relationship. It is important to note that the L. crispatus cluster only contained 11 women, and that the temporality of our findings is unclear because our study was cross-sectional.…”
Section: Discussionsupporting
confidence: 81%
“…Microarray sample preparation, labeling, amplification and hybridization were described previously (Dols et al, 2011;Supplementary Information).…”
Section: Microarray Designmentioning
confidence: 99%
See 2 more Smart Citations
“…Although hybridization studies have targeted only a few well-known pathogens, the results are consistent with those of other studies that showed that the presence of one or more specific pathogens correlates well with a diagnosis of BV. The search for molecular tools for the diagnosis of BV has also included the use of microarray technology (48), although the utility of such assays for routine diagnostic purposes remains to be proven. Commercially available, FDA-approved assays that utilize molecular methods of detection are usually not directed at BV alone but include probes for other known causes of vaginitis, such as N. gonorrhoeae, Trichomonas vaginalis, Chlamydia trachomatis, and G. vaginalis.…”
Section: Non-culture-based Methods For Diagnosis Of Bvmentioning
confidence: 99%